DEREVEN’KOV et al.
7
15. Hondal RJ, Marino SM, Gladyshev VN. Selenocysteine in
thiol/disulfide-like exchange reactions. Antioxid Redox Signal.
2013;18:1675-1689.
16. Lothrop AP, Snider GW, Ruggles EL, Patel AS, Lees WJ, Hondal
RJ. Selenium as an electron acceptor during the catalytic mech-
anism of thioredoxin reductase. Biochemistry. 2014;53:654-663.
17. Xu J, Cheng Q, Arnér ESJ. Details in the catalytic mechanism of
mammalian thioredoxin reductase 1 revealed using point muta-
tions and juglone-coupled enzyme activities. Free Radic Biol
Med. 2016;94:110-120.
18. Lothrop AP, Snider GW. Compensating for the absence of
selenocysteine in high-molecular weight thioredoxin reduc-
tases: the electrophilic activation hypothesis. Biochemistry.
2014;53:664-674.
19. Skaff O, Pattison DI, Morgan PE, et al. Selenium-containing
amino acids are targets for myeloperoxidase-derived hypoth-
iocyanous acid: determination of absolute rate constants and
implications for biological damage. Biochem J. 2012;441:305-316.
20. Fox JL. Sodium dithionite reduction of flavin. FEBS Lett.
1974;39:53-55.
21. Sicilio F, Peterson MD. Ratio errors in pseudo first order reac-
tions. J Chem Educ. 1961;38:576-577.
22. Corbet JF. Pseudo first-order kinetics. J Chem Educ. 1972;49:
663.
23. Schulman SG. pH dependence of fluorescence of riboflavin and
related isoalloxazine derivatives. J Pharm Sci. 1971;60:628-631.
24. Arnold AP, Tan K-S, Rabenstein DL. Nuclear magnetic reso-
nance studies of the solution chemistry of metal complexes.
23. Complexation of methylmercury by selenohydryl-containing
amino acids and related molecules. Inorg Chem. 1986;25:2433-
2437.
25. Nauser T, Dockheer S, Kissner R, Koppenol WH. Catalysis of
electron transfer by selenocysteine. Biochemistry. 2006;45:6038-
6043.
26. Anderson RF. Energetics of the one-electron reduction steps of
riboflavin, FMN and FAD to their fully reduced forms. Biochim
Biophys Acta. 1983;722:158-162.
27. Mayhew SG. The effects of pH and semiquinone formation
on the oxidation-reduction potentials of flavin mononucleotide.
Eur J Biochem. 1999;265:698-702.
28. Holden JW, Main L. The kinetics and mechanism of the oxida-
tion of mercaptoethanol by riboflavin. Aust J Chem. 1977;30:1387-
1391.
29. Loechler EL, Hollocher TC. Reduction of flavins by thiols. 1.
Reaction mechanism from the kinetics of the attack and break-
down steps. J Am Chem Soc. 1980;102:7312-7321.
30. Loechler EL, Hollocher TC. Reduction of flavins by thiols. 2.
Spectrophotometric evidence for a thiol-C(4a) flavin adduct and
the kinetics of deprotonation of the -SH group of the dithiothre-
itol adduct. J Am Chem Soc. 1980;102:7322-7327.
31. Loechler EL, Hollocher TC. Reduction of flavins by thiols. 3. The
case for concerted N,S-acetal formation in attack and an early
transition state in breakdown. J Am Chem Soc. 1980;102:7328-
7334.
32. Miller SM, Massey V, Ballou D, et al. Use of a site-directed
triple mutant to trap intermediates: demonstration that the
flavin C(4a)-thiol adduct and reduced flavin are kinetically com-
petent intermediates in mercuric ion reductase. Biochemistry.
1990;29:2831-2841.
provide an additional explanation as to why the TrxR sys-
tem does not exploit direct reduction of the selenosulfide
bond by reduced flavin and uses instead transient reduc-
tion of a disulfide bond: the interaction of reduced flavin
with oxidized selenol is reversible and the equilibrium is
shifted toward the reverse reaction.
O RC I D
R E F E R E N C E S
1. Reich HJ, Hondal RJ. Why nature chose selenium. ACS Chem
Biol. 2016;11:821-841.
2. Cupp-Sutton KA, Ashby MT. Biological chemistry of hydro-
3. Labunskyy VM, Hatfield DL, Gladyshev VN. Selenoproteins:
molecular pathways and physiological roles. Physiol Rev.
2014;94:739-777.
4. Iwaoka M, Arai K. From sulfur to selenium. A new research
arena in chemical biology and biological chemistry. Curr Chem
Biol. 2013;7:2-24.
5. Holmgren A, Lu J. Thioredoxin and thioredoxin reductase: cur-
rent research with special reference to human disease. Biochem
Biophys Res Commun. 2010;396:120-124.
6. Lu J, Holmgren A. Thioredoxin system in cell death progression.
Antioxid Redox Signal. 2012;17:1738-1747.
7. Lu J, Holmgren A. The thioredoxin antioxidant system. Free
Radic Biol Med. 2014;66:75-87.
8. Matsuzawa A. Thioredoxin and redox signaling: roles of the
thioredoxin system in control of cell fate. Arch Biochem Biophys.
2017;617:101-105.
9. Arnér ESJ, Holmgren A. Physiological functions of thioredoxin
and thioredoxin reductase. Eur J Biochem. 2000;267:6102-6109.
10. Gromer S, Johansson L, Bauer H, et al. Active sites of thiore-
doxin reductases: why selenoproteins. Proc Natl Acad Sci USA.
2003;100:12618-12623.
11. Snider GW, Ruggles E, Khan N, Hondal RJ. Selenocysteine con-
fers resistance to inactivation by oxidation in thioredoxin reduc-
tase: comparison of selenium and sulfur enzymes. Biochemistry.
2013;52:5472-5481.
12. Nauser T, Steinmann D, Grassi G, Koppenol WH. Why seleno-
cysteine replaces cysteine in thioredoxin reductase: a radical
hypothesis. Biochemistry. 2014;53:5017-5022.
13. Zhong L, Arnér ESJ, Holmgren A. Structure and mechanism
of mammalian thioredoxin reductase: the active site is a redox-
active selenolthiol/selenenylsulfide formed from the conserved
cysteine-selenocysteine sequence. Proc Natl Acad Sci USA.
2000;97:5854-5859.
14. Cheng Q, Sandalova T, Lindqvist Y, Arnér ESJ. Crystal structure
and catalysis of the selenoprotein thioredoxin reductase 1. J Biol
Chem. 2009;284:3998-4008.